Waseem Qasim | International Private Patients

Professor Waseem Qasim is a Consultant in Immunology who works closely with the Bone Marrow Transplant department. His area of expertise is children with inherited immune disorders and cell therapies used in transplant. This includes molecular diagnostics, in particular immunology and genetic testing for immunodeficiency. He works as part of multi-disciplinary team for the preparation and management of children before and after transplantation, aiming to provide the most appropriate and best quality treatments for children.

使用语言：

English

Inherited and genetic defects of the immune system
Transplant and transplant immunology
Cell and gene therapy; gene editing

Management of children with inherited immune disorders who require bone marrow transplantation
Severe combined immune deficiency (SCID) including RAG, ADA and SCID-X1. Combined immune deficiency (CID)
Bare lymphocyte syndrome (MHC class II deficiency)
Chronic granulomatous disease
Leucocyte adhesion deficiency
Wiskott Aldrich, IPEX and other conditions

Training:

B Med Sci (Hons) in Immunology from Newcastle University
MBBS from Newcastle University
MRCP (UK)
MRCPCH (UK)
PhD Doctor of Philosophy – gene therapy from University College London

Membership:

Royal College of Paediatrics and Child Health
Royal College of Physicians

Cell and gene therapy
Retroviral and lentiviral vectors
Gene editing technology
Haematopoietic stem cell transplantation

视频

National Geographic. The challenges of cancer trials.

新闻
论文及文章发表

Baby girl is first in the world to be treated with 'designer immune cells'

Morfopoulou, S., Mee, ET., Connaughton, SM., Brown, JR., Gilmour, K., Chong, WK., Duprex, WP., Ferguson, D., Hubank, M., Hutchinson, C., Kaliakatsos, M., McQuaid, S., Paine, S., Plagnol, V., Ruis, C., Virasami, A., Zhan, H., Jacques, TS., Schepelmann, S., Qasim, W. 2017. Breuer J. Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis. Acta Neuropathol. 133(1) pp. 139 – 147.

Bacchelli, C., Moretti, FA., Carmo, M., Adams, S., Stanescu, HC., Pearce, K., Madkaikar, M., Gilmour, KC., Nicholas, AK., Woods, CG., Kleta, R., Beales, PL., Qasim, W., Gaspar, HB. 2017. Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency. J Allergy Clin Immunol. 139(2) pp. 634 – 642.

Morfopoulou, S., Brown, JR., Davies, EG., Anderson, G., Virasami, A., Qasim, W., Chong, WK., Hubank, M., Plagnol, V., Desforges, M., Jacques, TS., Talbot, PJ., Breuer, J. 2016. Human Coronavirus OC43 Associated with Fatal Encephalitis. N Engl J Med. 375(5) pp. 497 – 498.

Mock, U., Nickolay, L., Philip, B., Cheung, GW., Zhan, H., Johnston, IC., Kaiser, AD., Peggs, K., Pule, M., Thrasher, AJ., Qasim, W. 2016. Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy. Cytotherapy. 18(8) pp. 1002 – 1011.

Georgiadis, C., Syed, F., Petrova, A., Abdul-Wahab, A., Lwin, SM., Farzaneh, F., Chan, L., Ghani, S., Fleck, RA., Glover, L., McMillan, JR., Chen, M., Thrasher, AJ., McGrath, JA., Di, WL., Qasim, W. 2016. Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB. J Invest Dermatol. 136(1) pp. 284 - 292.

Hiwarkar, P., Qasim, W,. Ricciardelli, I., Gilmour, K., Quezada, S., Saudemont, A., Amrolia, P., Veys, P. 2015. Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells. Blood. 126(26) pp. 2882 – 2891.

Qasim, W., Brunetto, M., Gehring, AJ., Xue, SA., Schurich, A., Khakpoor, A., Zhan, H., Ciccorossi, P., Gilmour, K., Cavallone, D, Moriconi, F., Farzhenah, F., Mazzoni, A,. Chan, L., Morris, E., Thrasher, A., Maini, MK., Bonino, F., Stauss, H., Bertoletti, A. 2015. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. J Hepatol. 62(2) pp. 486 – 491.

Hassan, A., Lee, P., Maggina, P., Xu, JH., Moreira, D., Slatter, M., Nademi, Z., Worth, A.,Adams, S., Jones, A., Cale, C., Allwood, Z., Rao, K., Chiesa, R., Amrolia, P., Gaspar, H., Davies, EG., Veys, P., Gennery, A., Qasim, W. 2014. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency. J Allergy Clin Immunol. 133(6) pp. 1660 – 1666.

如您想转诊您的孩子，请填写下方的转诊申请表。我们的同事会在2个工作日内与您取得联系。